Source access required
CVR360 has not loaded official Danish source data for this company yet. No AI or financial conclusion is generated without source-backed facts.
KL
Konsulentfirmaet LG Pharma ApS
aktivCVR 44845016AnpartsselskabStevnsvej 79, 4600 KøgeVirksomhedsrådgivning og anden ledelsesrådgivning
- Latest accounts
- 2025
- Statement scope
- Standalone
- Verified
- 06 Nov 2026
- Sources
- 5
What changed?
Source-backed changes, not an assessment.
1 source
Key figures
Latest period: 2025
Revenue
Not disclosed—
Not disclosed
Operating profit
DKK 214.9k
Latest period
Source details
Source: dk-regnskabsdata-live-44845016-1793946223337
Document: dk-regnskabsdata-44845016-AZ4c4h5UflpRAlmqT8hY-1
XBRL: fsa:ProfitLossFromOrdinaryOperatingActivities
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: duration_only_0
Unit: DKK
Net result
DKK 160.8k
Latest period
Source details
Source: dk-regnskabsdata-live-44845016-1793946223337
Document: dk-regnskabsdata-44845016-AZ4c4h5UflpRAlmqT8hY-1
XBRL: fsa:ProfitLoss
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: duration_only_0
Unit: DKK
Equity
DKK 512.1k
Equity ratio: 50%
Source details
Source: dk-regnskabsdata-live-44845016-1793946223337
Document: dk-regnskabsdata-44845016-AZ4c4h5UflpRAlmqT8hY-1
XBRL: fsa:Equity
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: instant_only_0
Unit: DKK
Development
Reported values. Missing periods appear as gaps.
RevenueNet result
Tabular view of development
| Year | Revenue | Net result |
|---|---|---|
| 2024 | — | DKK 18.3k |
| 2025 | — | DKK 160.8k |